Jie-wei Luo

484 total citations
67 papers, 307 citations indexed

About

Jie-wei Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Jie-wei Luo has authored 67 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Rheumatology. Recurrent topics in Jie-wei Luo's work include Urinary Bladder and Prostate Research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Ion channel regulation and function (4 papers). Jie-wei Luo is often cited by papers focused on Urinary Bladder and Prostate Research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Ion channel regulation and function (4 papers). Jie-wei Luo collaborates with scholars based in China and South Korea. Jie-wei Luo's co-authors include Jianbin Huang, Xing Lin, Jingjing Li, Jin Zhao, Dan‐dan Ruan, Zhu-ting Fang, Hanlu Wang, Jianhui Zhang, Liu Gui and Qiuyan Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Chemistry and Scientific Reports.

In The Last Decade

Jie-wei Luo

57 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie-wei Luo China 9 122 49 36 33 27 67 307
Wen Zhong China 9 107 0.9× 26 0.5× 31 0.9× 32 1.0× 34 1.3× 33 293
Irina M. Jaba Romania 10 132 1.1× 50 1.0× 48 1.3× 47 1.4× 63 2.3× 20 330
Gaaminepreet Singh India 10 73 0.6× 36 0.7× 31 0.9× 16 0.5× 29 1.1× 26 278
Qingqing Wang China 11 112 0.9× 69 1.4× 49 1.4× 38 1.2× 33 1.2× 27 296
Qingfu Zeng China 9 113 0.9× 29 0.6× 53 1.5× 28 0.8× 17 0.6× 23 263
Hongxin Niu China 13 134 1.1× 22 0.4× 35 1.0× 24 0.7× 22 0.8× 21 371
Hilary Cassidy Ireland 12 141 1.2× 19 0.4× 52 1.4× 36 1.1× 41 1.5× 19 360
Shilan Zhang China 9 104 0.9× 37 0.8× 50 1.4× 32 1.0× 63 2.3× 23 385
Fen Zhang China 12 134 1.1× 53 1.1× 30 0.8× 34 1.0× 84 3.1× 21 389
Tianyu Zhai China 14 146 1.2× 33 0.7× 29 0.8× 85 2.6× 48 1.8× 24 351

Countries citing papers authored by Jie-wei Luo

Since Specialization
Citations

This map shows the geographic impact of Jie-wei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie-wei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie-wei Luo more than expected).

Fields of papers citing papers by Jie-wei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie-wei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie-wei Luo. The network helps show where Jie-wei Luo may publish in the future.

Co-authorship network of co-authors of Jie-wei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jie-wei Luo. A scholar is included among the top collaborators of Jie-wei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie-wei Luo. Jie-wei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ting, Xiaoyan Liu, Yongqi He, et al.. (2025). Seven novel sesquiterpenes with hemostasis activities from leaves of Callicarpa nudiflora. Bioorganic Chemistry. 158. 108325–108325.
2.
Huang, Zheng, et al.. (2025). A Smart Self‐Immobilization Magnetic Resonance Contrast Agent for Delayed Tumor Imaging In Vivo. Angewandte Chemie International Edition. 64(52). e16998–e16998.
3.
Tian, Yuyang, Ruifang Chen, Yi Miao, et al.. (2025). Self‐Assembled Triple‐Targeted Radiosensitizer Enhances Hypoxic Tumor Targeting and Radio‐Immunotherapy Efficacy. Angewandte Chemie. 137(18). 3 indexed citations
4.
Liu, Xueyan, Jinyu Liu, Jian Zhong, et al.. (2025). AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy. Pharmacological Research. 218. 107834–107834.
5.
Zhou, Yanfeng, Ziyan Xu, Lijun Xie, et al.. (2025). Fasudil targets the RhoA/ROCK-NLRP3 axis to attenuate aristolochic acid-induced renal pyroptosis: translational validation by in vivo molecular imaging. International Immunopharmacology. 168(Pt 2). 115888–115888.
6.
7.
Yu, Hongping, Jing Zou, Xiang Chen, et al.. (2024). A novel stoploss mutation CYB5R3 c.906A>G(p.*302Trpext*42) involved in the pathogenesis of hereditary methemoglobinemia. Clinica Chimica Acta. 564. 119930–119930.
8.
9.
10.
Zhang, Jianhui, Dan‐dan Ruan, Min Wu, et al.. (2024). A rare concurrence of acute tubular necrosis and chronic glomerular sclerosis in a patient with wasp stings. Heliyon. 10(14). e34353–e34353. 2 indexed citations
11.
Wang, Hanlu, Dan‐dan Ruan, Min Wu, et al.. (2023). Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency. Thrombosis Journal. 21(1). 3–3. 8 indexed citations
12.
Wu, Yulin, Qian Chen, Yi Tang, et al.. (2023). Case Report: Imaging features of a new type double inferior vena cava malformation and review. Frontiers in Cardiovascular Medicine. 10. 1298071–1298071. 1 indexed citations
13.
Zhang, Jianhui, Yuanyuan Ji, Yanan Hu, et al.. (2022). Analysis of a Family with Brugada Syndrome and Sudden Cardiac Death Caused by a Novel Mutation of SCN5A. Cardiology Research and Practice. 2022. 1–11. 3 indexed citations
14.
Hu, Yanan, Weixiang Chen, Lisheng Liao, et al.. (2022). Clinical and Genetic Analysis of a Family With Sitosterolemia Caused by a Novel ATP-Binding Cassette Subfamily G Member 5 Compound Heterozygous Mutation. Frontiers in Cardiovascular Medicine. 9. 887618–887618. 1 indexed citations
15.
Pan, Xian, Hanlu Wang, Shi‐Ming Lin, et al.. (2022). A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report. Frontiers in Oncology. 12. 892943–892943. 1 indexed citations
16.
Ruan, Dan‐dan, et al.. (2021). Mutational Analysis of a Familial Adenomatous Polyposis Pedigree with Bile Duct Polyp Phenotype. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 6610434–6610434. 2 indexed citations
17.
18.
Tang, Yi, et al.. (2020). Effect of superselective prostatic artery embolization on benign prostatic hyperplasia. Abdominal Radiology. 46(4). 1726–1736. 5 indexed citations
19.
Chen, Li, et al.. (2020). Screening and function discussion of a hereditary renal tubular acidosis family pathogenic gene. Cell Death and Disease. 11(3). 159–159. 6 indexed citations
20.
Luo, Jie-wei, et al.. (2016). Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine. Chinese Journal of Integrative Medicine. 23(6). 461–468. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Zhong Breakdown of academic impact, for papers by Irina M. Jaba Breakdown of academic impact, for papers by Gaaminepreet Singh Breakdown of academic impact, for papers by Qingqing Wang Breakdown of academic impact, for papers by Qingfu Zeng Breakdown of academic impact, for papers by Hongxin Niu Breakdown of academic impact, for papers by Hilary Cassidy Breakdown of academic impact, for papers by Shilan Zhang Breakdown of academic impact, for papers by Fen Zhang Breakdown of academic impact, for papers by Tianyu Zhai
Rankless by CCL
2026